Veracyte (VCYT) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to -$315.6 million.
- Veracyte's Enterprise Value fell 1513.94% to -$315.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$315.6 million, marking a year-over-year decrease of 1513.94%. This contributed to the annual value of -$239.1 million for FY2024, which is 1045.63% down from last year.
- According to the latest figures from Q3 2025, Veracyte's Enterprise Value is -$315.6 million, which was down 1513.94% from -$219.5 million recorded in Q2 2025.
- In the past 5 years, Veracyte's Enterprise Value ranged from a high of -$153.4 million in Q2 2022 and a low of -$327.5 million during Q2 2021
- For the 5-year period, Veracyte's Enterprise Value averaged around -$215.7 million, with its median value being -$202.5 million (2023).
- In the last 5 years, Veracyte's Enterprise Value plummeted by 12213.97% in 2021 and then surged by 5315.24% in 2022.
- Veracyte's Enterprise Value (Quarter) stood at -$173.2 million in 2021, then rose by 10.94% to -$154.2 million in 2022, then crashed by 40.33% to -$216.5 million in 2023, then dropped by 10.46% to -$239.1 million in 2024, then crashed by 31.99% to -$315.6 million in 2025.
- Its Enterprise Value stands at -$315.6 million for Q3 2025, versus -$219.5 million for Q2 2025 and -$186.1 million for Q1 2025.